Breye Therapeutics provides treatment solutions for patients at risk of vision loss and blindness by developing orally administered therapies for patients with deteriorating vision from retinal vascular diseases within ophthalmology.

Imagenomix delivers rapid and affordable cancer diagnostic results through advanced AI capabilities so patients receive effective, targeted treatments for their specific cancer type.

Cytospire is developing next generation γδ T cell engagers into impactful cancer therapies.

Pioneering a new category of biotechnology to treat and prevent disease.

Eridu is the pioneer advancing the frontier in AI networking with a solution built from the ground up to deliver the bandwidth, performance and reliability at scale needed by AI data
centers.

Proxima is pioneering the next generation of AI-driven drug discovery for proximity-based therapeutics.

Exciva is developing a groundbreaking therapy that effectively and safely addresses neuropsychiatric symptoms of dementia including agitation/aggression in Alzheimer’s disease dementia.